Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

ダイトーケミックス

TAIHEI CHEMICALS

アイビー化粧品

関東電化工業

Nippon Shikizai

LTT Bio-Pharma

Carna Biosciences

KOEI CHEMICAL

HABA LABORATORIES

Kawaguchi Chemical Industry

小野産業

TAOKA CHEMICAL

廣貫堂

Maruto Sangyo

日本化学工業

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NIPPON COKE & ENGINEERING

Yushiro Chemical Indutry

日本セラミック etc.

日本セラミック etc.

日本セラミック etc.

Financial Indicator Details: 日本化学工業 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: 日本化学工業 (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	2.06% (-12.05%)	-2.18% (-0.50%)	-0.54% (1.53%)	-1.48% (-1.67%)	-21.37% (3.05%)
C/F margin (Industry Average)	1.12% (-3.31%)	20.85% (8.51%)	14.43% (7.04%)	5.26% (6.35%)	2.51% (8.25%)
ROA (Industry Average)	1.40% (0.52%)	-1.29% (1.04%)	-0.35% (2.07%)	-0.82% (0.06%)	-12.10% (2.71%)
ROE (Industry Average)	3.07% (-1.43%)	-2.81% (0.03%)	-0.71% (2.96%)	-1.66% (4.68%)	-28.98% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	-3.37% (5.01%)	-2.36% (2.61%)	-3.33% (-0.40%)	-21.26% (8.16%)
Sales growth (Industry Average)	- (-)	-15.99% (-2.67%)	-1.20% (5.36%)	-16.63% (1.07%)	-5.28% (2.24%)
Net profit growth (Industry Average)	- (-)	-188.66% (203.46%)	75.19% (63.25%)	-125.11% (3.89%)	-1,267.71% (90.38%)
Operating C/F growth (Industry Average)	- (-)	1,463.86% (275.10%)	-31.60% (35.09%)	-69.62% (-6.09%)	-54.68% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	45.79% (53.80%)	46.02% (54.51%)	49.58% (55.00%)	49.16% (53.59%)	41.75% (56.30%)
Liquidity ratio (Industry Average)	120.76% (217.72%)	124.31% (225.70%)	122.26% (237.55%)	124.59% (239.89%)	125.74% (236.21%)
C/F ratio current liabilities (Industry Average)	4,958.31% (777.21%)	283.55% (303.31%)	354.07% (434.79%)	1,133.97% (929.73%)	2,158.56% (573.30%)
Quick ratio (Industry Average)	61.25% (138.97%)	82.53% (148.85%)	78.71% (156.17%)	70.35% (160.84%)	70.52% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	63.78day (83.89day)	94.58day (94.27day)	80.83day (93.96day)	102.57day (97.92day)	99.87day (98.27day)
Inventory turnover (Industry Average)	109.54day (54.45day)	78.85day (52.58day)	71.92day (52.64day)	99.28day (56.59day)	97.64day (58.68day)
Payable turnover (Industry Average)	27.98day (45.01day)	42.25day (49.82day)	32.20day (49.52day)	56.23day (52.10day)	48.95day (51.12day)
Working capita turnover (Industry Average)	145.33day (93.32day)	131.18day (97.02day)	120.55day (97.08day)	145.63day (102.41day)	148.56day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	41.78% (34.57%)	-15.17% (1.49%)	-25.26% (-3.85%)	-19.01% (21.16%)
Dividend Yield (Industry Average)	4.98% (3.20%)	2.62% (1.93%)	2.58% (2.17%)	3.44% (2.45%)	- (2.07%)
PER (Industry Average)	13.65% (25.22%)	-21.84% (23.06%)	-74.68% (16.22%)	-24.79% (29.19%)	-1.46% (16.58%)
PBR (Industry Average)	0.41% (0.86%)	0.61% (1.06%)	0.53% (1.04%)	0.41% (0.95%)	0.42% (1.08%)
PCFR (Industry Average)	25.21% (7.18%)	2.28% (9.23%)	2.83% (-2.43%)	6.97% (9.50%)	12.46% (7.56%)
PSR (Industry Average)	0.28% (0.77%)	0.47% (0.88%)	0.40% (1.10%)	0.36% (0.90%)	0.31% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	1.88% (-27.66%)	-2.15% (-4.34%)	-0.68% (-5.37%)	-2.48% (-10.69%)	-25.68% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	1.20% (0.52%)	-1.22% (0.92%)	-0.41% (1.42%)	-1.21% (-0.27%)	-13.05% (1.53%)
ROE (Industry Average)	2.66% (-0.84%)	-2.67% (-0.46%)	-0.84% (1.81%)	-2.45% (3.42%)	-32.20% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	-3.25% (3.64%)	-2.54% (3.03%)	-4.15% (0.04%)	-23.12% (3.91%)
Sales growth (Industry Average)	- (-)	-14.99% (-3.48%)	-2.73% (6.70%)	-23.72% (0.75%)	-2.40% (-1.74%)
Net profit growth (Industry Average)	- (-)	-197.06% (166.48%)	69.12% (43.48%)	-176.86% (-47.04%)	-910.19% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	45.20% (56.79%)	45.57% (57.65%)	49.33% (57.17%)	49.54% (55.93%)	40.53% (57.57%)
Liquidity ratio (Industry Average)	115.85% (337.22%)	119.21% (276.75%)	116.08% (266.94%)	118.43% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	56.32% (167.28%)	77.08% (183.78%)	71.57% (174.83%)	60.62% (228.06%)	- (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	63.08day (87.55day)	92.62day (98.39day)	80.85day (95.88day)	97.80day (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	115.05day (50.17day)	80.31day (48.43day)	74.18day (47.43day)	111.35day (50.67day)	- (38.21day)
Payable turnover (Industry Average)	26.46day (45.70day)	39.94day (51.63day)	28.75day (51.13day)	47.53day (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	151.68day (92.02day)	132.98day (95.19day)	126.29day (92.19day)	161.62day (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	41.78% (34.46%)	-15.17% (3.11%)	-25.26% (-3.30%)	-19.01% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	16.56% (34.12%)	-24.19% (27.80%)	-66.48% (13.58%)	-17.94% (22.26%)	-1.43% (26.42%)
PBR (Industry Average)	0.44% (0.97%)	0.64% (1.21%)	0.56% (1.17%)	0.43% (1.08%)	0.46% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.31% (3.42%)	0.52% (4.34%)	0.45% (3.67%)	0.44% (4.37%)	0.36% (10.14%)

Financial Indicator Details: 日本化学工業

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	2.06%	-2.18%	-0.54%	-1.48%	-21.37%
C/F margin	1.12%	20.85%	14.43%	5.26%	2.51%
ROA	1.40%	-1.29%	-0.35%	-0.82%	-12.10%
ROE	3.07%	-2.81%	-0.71%	-1.66%	-28.98%
Recurring margin	1.85%	-2.62%	2.74%	-3.03%	-5.42%
EBIT margin	3.81%	-2.00%	0.14%	-2.71%	-21.48%
EBITDA margin	13.49%	8.36%	9.37%	8.51%	-10.46%
NOPAT margin	2.29%	-1.20%	0.08%	-1.63%	-12.88%
Sales SG rates	84.08%	87.11%	82.07%	85.41%	87.52%
Sales SG&A rates	13.17%	13.95%	14.58%	16.87%	16.74%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	9.67%	10.37%	9.22%	11.22%	11.01%
Capital expenditures net sales ratio	-7.49%	-5.87%	-7.45%	-8.30%	-6.44%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	16.21%	-21.93%	-36.10%	-25.18%
Equity growth	-	-3.37%	-2.36%	-3.33%	-21.26%
Total assets growth	-	-3.85%	-9.37%	-2.51%	-7.28%
Sales growth	-	-15.99%	-1.20%	-16.63%	-5.28%
Net profit growth	-	-188.66%	75.19%	-125.11%	-1,267.71%
Operating C/F growth	-	1,463.86%	-31.60%	-69.62%	-54.68%
Recurring profit growth	-	-218.93%	203.36%	-192.34%	-69.20%
EBIT growth	-	-144.09%	107.14%	-1,663.33%	-648.72%
EBITDA growth	-	-47.90%	10.63%	-24.29%	-216.47%
NOPAT growth	-	-144.09%	107.14%	-1,663.33%	-648.72%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	45.79%	46.02%	49.58%	49.16%	41.75%
Liquidity ratio	120.76%	124.31%	122.26%	124.59%	125.74%
C/F ratio current liabilities	4,958.31%	283.55%	354.07%	1,133.97%	2,158.56%
Quick ratio	61.25%	82.53%	78.71%	70.35%	70.52%
Fixed ratio	103.52%	104.84%	102.62%	102.03%	113.89%
D/E ratio	77.03%	67.07%	54.76%	53.54%	42.74%
Loan to Value Ratio	35.27%	30.87%	27.15%	26.32%	17.84%
Business investment C/F ratio	-668.87%	-28.17%	-51.64%	-157.92%	-255.89%
Liabilities with interest growth	-	-15.86%	-20.27%	-5.49%	-37.15%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	60.41day	83.58day	66.04day	50.62day	39.99day
Receivables turnover	63.78day	94.58day	80.83day	102.57day	99.87day
Inventory turnover	109.54day	78.85day	71.92day	99.28day	97.64day
Fixed assets turnover	254.35day	296.33day	286.65day	330.45day	306.64day
Total asset turnover	536.53day	614.08day	563.30day	658.71day	644.81day
Payable turnover	27.98day	42.25day	32.20day	56.23day	48.95day
Capital turnover	42.11day	50.13day	50.74day	60.87day	64.27day
Equity turnover	245.70day	282.62day	279.32day	323.87day	269.23day
Working capita turnover	145.33day	131.18day	120.55day	145.63day	148.56day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 8 B	¥ 9 B	¥ 7 B	¥ 4 B	¥ 3 B
Accounts receivable-trade	¥ 8 B	¥ 10 B	¥ 9 B	¥ 9 B	¥ 8 B
Other Current Assets	¥ 25 B	¥ 21 B	¥ 18 B	¥ 20 B	¥ 18 B
Current Assets	¥ 33 B	¥ 30 B	¥ 25 B	¥ 25 B	¥ 22 B
Tangible Assets	¥ 34 B	¥ 34 B	¥ 32 B	¥ 31 B	¥ 27 B
Intangible Assets	¥ 585 M	¥ 524 M	¥ 456 M	¥ 402 M	¥ 2 B
Investment etc.	¥ 4 B	¥ 5 B	¥ 5 B	¥ 4 B	¥ 5 B
Total Assets	¥ 73 B	¥ 70 B	¥ 63 B	¥ 62 B	¥ 57 B
Current Liabilities	¥ 27 B	¥ 24 B	¥ 21 B	¥ 20 B	¥ 17 B
Fixed Liabilities	¥ 12 B	¥ 13 B	¥ 11 B	¥ 11 B	¥ 15 B
Liabilities with interest	¥ 25 B	¥ 21 B	¥ 17 B	¥ 16 B	¥ 10 B
Net Assets	¥ 33 B	¥ 32 B	¥ 31 B	¥ 30 B	¥ 24 B
Capital stock	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B
Capital surplus etc.	¥ 27 B	¥ 26 B	¥ 25 B	¥ 24 B	¥ 18 B
Liabilities and net assets	¥ 73 B	¥ 70 B	¥ 63 B	¥ 62 B	¥ 57 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 49 B	¥ 41 B	¥ 41 B	¥ 34 B	¥ 32 B
Cost of Sales	¥ 41 B	¥ 36 B	¥ 33 B	¥ 29 B	¥ 28 B
Gross profit	¥ 7 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 4 B
Other income	¥ 1 B	¥ 642 M	¥ 410 M	¥ 1 B	¥ 655 M
SG&A	¥ 6 B	¥ 5 B	¥ 6 B	¥ 5 B	¥ 5 B
Other expenses	¥ 1 B	¥ 1 B	¥ 2 B	¥ 807 M	¥ 6 B
Net income	¥ 1 B	¥ -915 M	¥ -227 M	¥ -511 M	¥ -6 B
Operating income	¥ 1 B	¥ -450 M	¥ 1 B	¥ -792 M	¥ -1 B
Ordinary Income	¥ 924 M	¥ -1 B	¥ 1 B	¥ -1 B	¥ -1 B
EBITDA	¥ 6 B	¥ 3 B	¥ 3 B	¥ 2 B	¥ -3 B
Income before income taxes	¥ 1 B	¥ -1 B	¥ -305 M	¥ -1 B	¥ -7 B
Depreciation	¥ 4 B	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 396 M	¥ -392 M	¥ -78 M	¥ -729 M	¥ -327 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 559 M	¥ 8 B	¥ 5 B	¥ 1 B	¥ 823 M
Investment CF	¥ -3 B	¥ -2 B	¥ -3 B	¥ -3 B	¥ -4 B
Financial CF	¥ 8 B	¥ -4 B	¥ -4 B	¥ -1 B	¥ 2 B
Foreign Exchange Effects	¥ -1 M	¥ -1 M	¥ -3 M	-	¥ 11 M
Net Change in Cash	¥ 5 B	¥ 1 B	¥ -2 B	¥ -2 B	¥ -1 B
Free CF	¥ -2 B	¥ 5 B	¥ 2 B	¥ -1 B	¥ -3 B
Capital expenditures	¥ -3 B	¥ -2 B	¥ -3 B	¥ -2 B	¥ -2 B
Cash dividends paid	¥ -703 M	¥ -525 M	¥ -439 M	¥ -437 M	¥ -1 M
Repayment loans	¥ -2 B	¥ -4 B	¥ -2 B	¥ -3 B	¥ -5 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -703 M	¥ -527 M	¥ -439 M	¥ -439 M	-
Net income	¥ 1 B	¥ -915 M	¥ -227 M	¥ -511 M	¥ -6 B
Purchase of treasury stock	¥ -2 M	-	-	-	-
Other Change in Stockholders Equity	¥ -1 M	¥ -1 M	¥ -2 M	¥ -2 M	-
Other Change in Net Assets	¥ -675 M	¥ 311 M	¥ -99 M	¥ -106 M	¥ 475 M
Net Change in Net Assets	¥ -349 M	¥ -1 B	¥ -767 M	¥ -1 B	¥ -6 B

Financial Indicator Details: 日本化学工業

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	1.88%	-2.15%	-0.68%	-2.48%	-25.68%
C/F margin	-	-	-	-	-
ROA	1.20%	-1.22%	-0.41%	-1.21%	-13.05%
ROE	2.66%	-2.67%	-0.84%	-2.45%	-32.20%
Recurring margin	1.52%	-2.71%	2.86%	-4.62%	-7.09%
EBIT margin	3.70%	-2.05%	-0.01%	-4.24%	-
EBITDA margin	4.38%	-1.47%	0.47%	-3.47%	-
NOPAT margin	2.22%	-1.23%	-	-2.54%	-
Sales SG rates	84.85%	87.95%	82.41%	85.96%	125.68%
Sales SG&A rates	12.68%	13.09%	14.04%	17.77%	-
Sales R&D expenses rates	4.76%	5.17%	5.63%	6.75%	-
Sales depreciation rates	0.68%	0.58%	0.49%	0.77%	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	17.65%	-29.39%	-41.23%	-100.00%
Equity growth	-	-3.25%	-2.54%	-4.15%	-23.12%
Total assets growth	-	-4.03%	-9.96%	-4.57%	-6.03%
Sales growth	-	-14.99%	-2.73%	-23.72%	-2.40%
Net profit growth	-	-197.06%	69.12%	-176.86%	-910.19%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	-251.67%	202.59%	-223.19%	-49.65%
EBIT growth	-	-147.12%	99.23%	-20,050.00%	100.00%
EBITDA growth	-	-128.53%	131.32%	-658.19%	100.00%
NOPAT growth	-	-147.12%	99.23%	-20,050.00%	100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	45.20%	45.57%	49.33%	49.54%	40.53%
Liquidity ratio	115.85%	119.21%	116.08%	118.43%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	56.32%	77.08%	71.57%	60.62%	-
Fixed ratio	108.19%	109.64%	107.63%	107.90%	-
D/E ratio	80.93%	70.39%	57.62%	56.96%	-
Loan to Value Ratio	36.58%	32.08%	28.42%	28.22%	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-15.85%	-20.22%	-5.26%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	59.71day	82.64day	59.99day	46.22day	-
Receivables turnover	63.08day	92.62day	80.85day	97.80day	-
Inventory turnover	115.05day	80.31day	74.18day	111.35day	-
Fixed assets turnover	279.03day	321.79day	316.54day	398.75day	-
Total asset turnover	570.49day	644.04day	596.14day	745.87day	718.10day
Payable turnover	26.46day	39.94day	28.75day	47.53day	-
Capital turnover	46.58day	54.79day	56.33day	73.86day	-
Equity turnover	257.89day	293.50day	294.08day	369.55day	291.10day
Working capita turnover	151.68day	132.98day	126.29day	161.62day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 7 B	¥ 8 B	¥ 6 B	¥ 3 B	-
Accounts receivable-trade	¥ 7 B	¥ 9 B	¥ 8 B	¥ 7 B	-
Other Current Assets	¥ 23 B	¥ 19 B	¥ 17 B	¥ 18 B	-
Current Assets	¥ 31 B	¥ 28 B	¥ 23 B	¥ 21 B	-
Tangible Assets	¥ 34 B	¥ 33 B	¥ 32 B	¥ 31 B	-
Intangible Assets	¥ 571 M	¥ 510 M	¥ 443 M	¥ 390 M	-
Investment etc.	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 54 B
Total Assets	¥ 70 B	¥ 67 B	¥ 60 B	¥ 58 B	¥ 54 B
Current Liabilities	¥ 26 B	¥ 23 B	¥ 20 B	¥ 18 B	¥ 32 B
Fixed Liabilities	¥ 11 B	¥ 12 B	¥ 10 B	¥ 10 B	-
Liabilities with interest	¥ 25 B	¥ 21 B	¥ 17 B	¥ 16 B	-
Net Assets	¥ 31 B	¥ 30 B	¥ 30 B	¥ 28 B	¥ 22 B
Capital stock	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	-
Capital surplus etc.	¥ 26 B	¥ 25 B	¥ 24 B	¥ 23 B	¥ 22 B
Liabilities and net assets	¥ 70 B	¥ 67 B	¥ 60 B	¥ 58 B	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 45 B	¥ 38 B	¥ 37 B	¥ 28 B	¥ 27 B
Cost of Sales	¥ 38 B	¥ 33 B	¥ 30 B	¥ 24 B	¥ 34 B
Gross profit	¥ 6 B	¥ 4 B	¥ 6 B	¥ 3 B	¥ -7 B
Other income	¥ 1 B	¥ 691 M	¥ 426 M	¥ 1 B	-
SG&A	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	-
Other expenses	¥ 1 B	¥ 1 B	¥ 2 B	¥ 802 M	-
Net income	¥ 851 M	¥ -826 M	¥ -255 M	¥ -706 M	¥ -7 B
Operating income	¥ 1 B	¥ -404 M	¥ 1 B	¥ -1 B	¥ -1 B
Ordinary Income	¥ 687 M	¥ -1 B	¥ 1 B	¥ -1 B	¥ -1 B
EBITDA	¥ 1 B	¥ -565 M	¥ 177 M	¥ -988 M	-
Income before income taxes	¥ 1 B	¥ -1 B	¥ -364 M	¥ -1 B	-
Depreciation	¥ 308 M	¥ 223 M	¥ 183 M	¥ 221 M	-
R&D expenses	¥ 2 B	¥ 1 B	¥ 2 B	¥ 1 B	-
Income taxes	¥ 350 M	¥ -425 M	¥ -108 M	¥ -798 M	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -703 M	¥ -527 M	¥ -439 M	¥ -439 M	-
Net income	¥ 851 M	¥ -826 M	¥ -255 M	¥ -706 M	-
Purchase of treasury stock	¥ -2 M	-	-	-	-
Other Change in Stockholders Equity	¥ -1 M	-	¥ -2 M	¥ -2 M	-
Other Change in Net Assets	¥ -675 M	¥ 317 M	¥ -88 M	¥ -101 M	-
Net Change in Net Assets	¥ -530 M	¥ -1 B	¥ -784 M	¥ -1 B	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: 日本化学工業 (Annual )

Statement Type

Annual : 日本化学工業

First quarter : 日本化学工業

Second quarter : 日本化学工業

Third quarter : 日本化学工業

Analysis Menu

Outline : 日本化学工業

Statement : 日本化学工業

Rating : 日本化学工業

Indicator : 日本化学工業

Download : 日本化学工業

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo江東区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
日本化学工業	4092	TSE 1st	Chemicals	3	Annual	CC

Related Company

ダイトーケミックス (Sales ¥ 8 B)

New Japan Chemical (Sales ¥ 28 B)

Carna Biosciences (Sales ¥ 510 M)

わかもと製薬 (Sales ¥ 9 B)

Nippon Shikizai (Sales ¥ 7 B)

Maruto Sangyo (Sales ¥ 13 B)

TAOKA CHEMICAL (Sales ¥ 17 B)

関東電化工業 (Sales ¥ 34 B)

アイビー化粧品 (Sales ¥ 4 B)

TAIHEI CHEMICALS (Sales ¥ 5 B)

HABA LABORATORIES (Sales ¥ 13 B)

小野産業 (Sales ¥ 3 B)

LTT Bio-Pharma (Sales ¥ 61 M)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .